Rixheim, France

Pierre Barbier

This inventor holds 17 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignee: Hoffmann-La Roche Inc.. Active years: 1990-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pierre Barbier. Retrieved from https://idiyas.com/inventor/pierre-barbier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 94.1

Average Co-Inventor Count = 3.7

ph-index = 7

Forward Citations = 278(Granted Patents)


Company Filing History:


Years Active: 1990-2011

Loading Chart...
Areas of Expertise:
Orlistat Compositions
Gastrointestinal Side Effects
Cyclohexanediol Derivatives
Arylsecocholadiene Derivatives
Azepanes
Vitamin D Derivatives
Dihomo-seco-cholestanes
Protein Kinase Inhibitors
Oxetanones
Dermatological Applications
Chemical Derivatives
Pharmaceutical Innovations
17 patents (USPTO):Explore Patents

Title: Pierre Barbier - Innovative French Inventor

Introduction: Pierre Barbier is a renowned inventor hailing from Rixheim, France, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Pierre Barbier holds several patents in diverse areas, showcasing his versatility and creativity in inventing new solutions to existing problems.

Career Highlights: Throughout his illustrious career, Pierre Barbier has consistently pushed the boundaries of innovation, with his inventions making a significant impact in industries such as technology, healthcare, and sustainability.

Collaborations: Pierre Barbier has collaborated with leading companies, research institutions, and universities to further develop and implement his inventions, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Pierre Barbier's passion for innovation and his dedication to creating solutions that improve lives have solidified his reputation as a pioneering inventor in the global innovation landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…